Screening Novel Agent Combinations to Expedite CTCL Therapeutic Development
Published: 19 April 2020| Version 1 | DOI: 10.17632/hpvnkrshdg.1
Contributor:
Fatima MirzaDescription
High-throughput screening on patient-derived malignant cutaneous T cell lymphoma cells.
Files
Institutions
Yale University
Categories
Dermatology, Oncology